Treatment of venous thromboembolism with low-molecular-weight heparin
โ Scribed by Russell D. Hull; Graham F. Pineo
- Publisher
- Springer US
- Year
- 1995
- Tongue
- English
- Weight
- 785 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0929-5305
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Outpatient treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH) seems as safe and effective as inpatient treatment with unfractionated heparin (UFH). However, most of the randomized trials comparing a LMWH with UFH described clinical outcomes within 3โ6 mon
This study tests the feasibility of inhalable pegylated liposomal formulations of low molecular weight heparin (LMWH) for treatment of two clinical manifestations of vascular thromboembolism: deep vein thrombosis (DVT) and pulmonary embolism (PE). Conventional distearoyl-sn-glycero-3-phosphoethanola